MERTRIAN Trademark

Trademark Overview


On Thursday, May 16, 2019, a trademark application was filed for MERTRIAN with the United States Patent and Trademark Office. The USPTO has given the MERTRIAN trademark a serial number of 79261241. The federal status of this trademark filing is REGISTERED as of Tuesday, January 21, 2020. This trademark is owned by Glaxo Group Limited. The MERTRIAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
mertrian

General Information


Serial Number79261241
Word MarkMERTRIAN
Filing DateThursday, May 16, 2019
Status700 - REGISTERED
Status DateTuesday, January 21, 2020
Registration Number5964203
Registration DateTuesday, January 21, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressGB

Trademark Events


Event DateEvent Description
Thursday, June 20, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, July 4, 2019ASSIGNED TO EXAMINER
Sunday, July 7, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, July 27, 2019REFUSAL PROCESSED BY MPU
Friday, August 16, 2019REFUSAL PROCESSED BY IB
Friday, June 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 25, 2019APPLICATION FILING RECEIPT MAILED
Saturday, July 6, 2019NON-FINAL ACTION WRITTEN
Saturday, July 27, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 30, 2019ASSIGNED TO LIE
Wednesday, October 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 16, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, November 1, 2019NOTIFICATION PROCESSED BY IB
Tuesday, November 5, 2019PUBLISHED FOR OPPOSITION
Tuesday, November 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 16, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, January 21, 2020REGISTERED-PRINCIPAL REGISTER
Friday, May 22, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 28, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, May 30, 2025NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, January 21, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, April 21, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 5, 2020FINAL DISPOSITION PROCESSED
Tuesday, May 5, 2020FINAL DISPOSITION NOTICE SENT TO IB